Published in:
01-11-2009 | Original Article
Management patterns of childhood-onset nephrotic syndrome
Authors:
Nathaniel MacHardy, Paul V. Miles, Susan F. Massengill, William E. Smoyer, John D. Mahan, Larry Greenbaum, Sara Massie, Lynne Yao, Shashi Nagaraj, Jen-Jar Lin, Delbert Wigfall, Howard Trachtman, Yichun Hu, Debbie S. Gipson
Published in:
Pediatric Nephrology
|
Issue 11/2009
Login to get access
Abstract
As an initial effort to identify opportunities to improve the management of children with nephrotic syndrome, the goal of this study was to assess the present-day management of children with primary nephrotic syndrome. A web-based survey was designed to assess the current management styles of all pediatric nephrology faculties at ten participating institutions. Ninety-one percent completed the initial survey. The duration of initial glucocorticoid therapy ranged from 4 to 24 weeks. Physicians reported that the recommendation for kidney biopsy was dependent on the response to initial corticosteroid therapy, with the minority always recommending a biopsy for frequently relapsing or steroid-dependent cases. All responding physicians recommended a kidney biopsy in steroid-resistant cases. Treatment strategies were reported to vary based upon the steroid response pattern and, where available, kidney histopathology. Striking variations in therapeutic preferences were described when alternatives to glucocorticoids were considered. The variability of management practices among pediatric nephrologists in the USA combined with the changing characteristics of our pediatric population raise concerns about our future strategies for improving healthcare for children coping with nephrotic syndrome. This variability is not unique to children’s healthcare or to nephrology. However, a systematic approach to patient care and improvement in health outcomes has been shown to substantially improve morbidity and mortality outcomes in children with chronic health conditions.